Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 10/20 | 1.00 |
| ▸ | LDHB | P07195 | 9/20 | 1.00 |
| ▸ | BCL2 | P10415 | 1/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | BCL2A1 | Q16548 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.40 |
| ▸ | NQO1 | P15559 | 1/20 | 0.40 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.40 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30417934 | 1.00 | LDHA (1.00) | LDHALDHBBCL2BCL2L1MCL1 | |
| SCHEMBL7179530 | 0.93 | LDHA (0.87) | LDHALDHBBCL2L1 | |
| SCHEMBL7187931 | 0.93 | LDHA (0.87) | LDHALDHBBCL2BCL2L1MCL1 | |
| SCHEMBL15322250 | 0.90 | LDHA (0.82) | LDHALDHBBCL2BCL2L1MCL1 | |
| SCHEMBL7185727 | 0.88 | LDHA (0.78) | LDHALDHBBCL2L1 | |
| SCHEMBL235873 | 0.84 | LDHA (1.00) | LDHALDHBPTPN1 | |
| SCHEMBL7179562 | 0.83 | LDHA (1.00) | LDHALDHBBCL2BCL2L1MCL1 | |
| SCHEMBL7180813 | 0.82 | LDHA (0.70) | LDHALDHB | |
| SCHEMBL2754182 | 0.81 | LDHA (0.71) | LDHALDHBPTPN1PTPN2 | |
| SCHEMBL7183463 | 0.80 | LDHA (1.00) | LDHALDHB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062555-A1 | SELENIUM-CONTAINING ANALOGUES OF PHEOMELANIN AND RELATED MATERIALS AND METHODS OF MAKING | NORTHWESTERN UNIVERSITY (US) | 2026-03-05 | — | — | US | claimed |
| US-12441890-B2 | Selenium-containing analogues of pheomelanin and related materials and methods of making | NORTHWESTERN UNIVERSITY (US) | 2025-10-14 | — | — | US | claimed |
| CN-119979222-A | Method and device for producing low-freezing diesel oil by taking heavy aromatic hydrocarbon and mixed diesel oil as raw materials | 中国石油天然气股份有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119868545-A | Nano system for regulating tumor acidic microenvironment and promoting light immune treatment effect and application thereof | 皖南医学院第一附属医院（皖南医学院弋矶山医院） | 2025-04-25 | — | — | CN | claimed |
| US-20250017950-A1 | COMPOUNDS FOR TREATING MITOCHONDRIAL DNA DISORDERS | UCL BUSINESS LTD (GB) | 2025-01-16 | — | — | US | claimed |
| CN-119176122-A | Reconfigurable distributed driving multi-axis vehicle track tracking method and carrying device | 东南大学 | 2024-12-24 | — | — | CN | claimed |
| EP-4433077-A1 | COMPOUNDS FOR TREATING MITOCHONDRIAL DNA DISORDERS | UCL Business Ltd (GB) | 2024-09-25 | — | — | EP | claimed |
| US-20240000949-A1 | Nucleic Acid-Derivatized Therapeutics | UNIV CHICAGO (US) | 2024-01-04 | — | — | US | claimed |
| WO-2023235559-A1 | SI-SUBSTITUTED LITHIUM THIOBORATE MATERIAL WITH HIGH LITHIUM ION CONDUCTIVITY FOR USE AS SOLID-STATE ELECTROLYTE AND ELECTRODE ADDITIVE | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2023-12-07 | — | — | WO | claimed |
| US-20230382749-A1 | PHOTODRIVEN TRANSFER HYDROGENATION OF N2 TO NH3 | CALIFORNIA INST OF TECHN (US) | 2023-11-30 | — | — | US | claimed |
| CN-116367849-A | Therapeutic agent derived from nucleic acid | 芝加哥大学 | 2023-06-30 | — | — | CN | claimed |
| US-20230193039-A1 | SELENIUM-CONTAINING ANALOGUES OF PHEOMELANIN AND RELATED MATERIALS AND METHODS OF MAKING | NORTHWESTERN UNIVERSITY (US) | 2023-06-22 | — | — | US | claimed |
| WO-2023089313-A1 | COMPOUNDS FOR TREATING MITOCHONDRIAL DNA DISORDERS | UCL BUSINESS LTD (GB) | 2023-05-25 | — | — | WO | claimed |
| CN-115753157-A | Load simulation device and method for hanger rod of suspension type monorail train | 中车南京浦镇车辆有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-115495156-A | Independent convolution 3x3 design method based on 4bit to 6bit | 北京君正集成电路股份有限公司 | 2022-12-20 | — | — | CN | claimed |
| CN-115397972-A | In vitro poultry food | 优良肉品公司 | 2022-11-25 | — | — | CN | claimed |
| US-11408897-B2 | Mass defect-based multiplex dimethyl pyrimidinyl ornithine (DiPyrO) tags for high-throughput quantitative proteomics and peptidomics | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2022-08-09 | — | — | US | claimed |
| EP-3983529-A1 | IN VITRO AVIAN FOOD PRODUCT | Good Meat, Inc. (US) | 2022-04-20 | — | — | EP | claimed |
| WO-2022006387-A9 | FULLY AND PARTIALLY BACKBONE-DEGRADABLE POLYMERS VIA LOW TEMPERATURE RING-OPENING METATHESIS POLYMERIZATION (ROMP) | NORTHWESTERN UNIVERSITY (US) | 2022-04-14 | — | — | WO | claimed |
| US-20220098674-A1 | METHODS AND COMPOSITIONS FOR SELECTING A CANCER TREATMENT IN A SUBJECT SUFFERING FROM CANCER | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS - (FR) | 2022-03-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230193039-A1 | SELENIUM-CONTAINING ANALOGUES OF PHEOMELANIN AND RELATED MATERIALS AND METHODS OF MAKING | SELENOI, SCLY, SELP | LDHA 3813/4885LDHB 3660/4885BCL2 4409/4885 |
| US-11408897-B2 | Mass defect-based multiplex dimethyl pyrimidinyl ornithine (DiPyrO) tags for high-throughput quantitative proteomics and peptidomics | PTMS, SRMS, CHAMP1 | LDHA 3504/4885LDHB 3305/4885BCL2 4877/4885 |
| US-12441890-B2 | Selenium-containing analogues of pheomelanin and related materials and methods of making | SELENOI, SCLY, SELP | LDHA 3813/4885LDHB 3660/4885BCL2 4409/4885 |
| US-20260062555-A1 | SELENIUM-CONTAINING ANALOGUES OF PHEOMELANIN AND RELATED MATERIALS AND METHODS OF MAKING | TYR, MPO, SCLY | LDHA 3270/4885LDHB 3196/4885BCL2 1956/4885 |
| US-20250017950-A1 | COMPOUNDS FOR TREATING MITOCHONDRIAL DNA DISORDERS | POLRMT, TK2, GOT2 | LDHA 266/4885LDHB 309/4885BCL2 867/4885 |
| US-20240000949-A1 | Nucleic Acid-Derivatized Therapeutics | NSUN2, NSUN3, POLRMT | LDHA 217/4885LDHB 186/4885BCL2 1497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.